Keyword

PAINS

Description: Pan-assay interference compounds are chemical compounds that produce misleading activity across multiple screening assays, complicating early-stage drug discovery.
Wikidata ID: wiki/Q25101047
OpenAlex ID: keywords/pains
2017 · Kathryn M. Nelson, Jayme L. Dahlin, et al. · Journal of Medicinal Chemistry · 2,219
2017 · Jonathan B. Baell, J. Willem M. Nissink · ACS Chemical Biology · 732
2020 · Qifeng Bai, Shuoyan Tan, et al. · Briefings in Bioinformatics · 314
2015 · David Lagorce, Olivier Sperandio, et al. · Nucleic Acids Research · 299
2017 · Stephen J. Capuzzi, Eugene N. Muratov, et al. · Journal of Chemical Information and Modeling · 290
2015 · Jonathan Bisson, James B. McAlpine, et al. · Journal of Medicinal Chemistry · 278
2017 · Danylo Kaminskyy, Anna Kryshchyshyn, et al. · European Journal of Medicinal Chemistry · 203
2012 · Tihomir Tomašić, Lucija Peterlin Mašič · Expert Opinion on Drug Discovery · 190
2017 · Courtney Aldrich, Carolyn Bertozzi, et al. · Journal of Medicinal Chemistry · 187
2010 · R. Sink, S. Gobec, et al. · Current Medicinal Chemistry · 145
2015 · Martin Pouliot, Stephane Jeanmart · Journal of Medicinal Chemistry · 143
2017 · Danylo Kaminskyy, Anna Kryshchyshyn, et al. · Expert Opinion on Drug Discovery · 126
2023 · Sebastjan Kralj, Marko Jukič, et al. · Encyclopedia · 122
2021 · Sarah Naomi Bolz, Melissa F. Adasme, et al. · Journal of Chemical Information and Modeling · 115
2019 · Conrad Stork, Ya Chen, et al. · Journal of Chemical Information and Modeling · 114
2016 · Mario R. Senger, Carlos A.M. Fraga, et al. · Drug Discovery Today · 99
2011 · David Lagorce, Julien Maupetit, et al. · Bioinformatics · 98
2013 · Jonathan B. Baell, Lori Ferrins, et al. · Australian Journal of Chemistry · 97
2015 · Jayme L. Dahlin, Michael A. Walters · Assay and Drug Development Technologies · 92
Works count: 361
Citation count: 14,770
Year
Topic
Type